Klotho Neurosciences, Inc.

NasdaqGM:KLTO Stock Report

Market Cap: US$7.7m

Klotho Neurosciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Joe Sinkule

Chief executive officer

US$853.0k

Total compensation

CEO salary percentage35.2%
CEO tenure1.1yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joe Sinkule's remuneration changed compared to Klotho Neurosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$4m

Jun 30 2024n/an/a

-US$1m

Mar 31 2024n/an/a

-US$1m

Dec 31 2023US$160kUS$160k

-US$707k

Compensation vs Market: Joe's total compensation ($USD853.00K) is above average for companies of similar size in the US market ($USD638.68K).

Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.

CEO

Joe Sinkule (70 yo)

1.1yrs

Tenure

US$853,000

Compensation

Dr. Joseph Sinkule, also known as Joe, Pharm D, is Chairman of the Board of Klotho Neurosciences, Inc. (formerly known as Anew Medical, Inc.) since 2024 and was its Chief Financial Officer until 2024. Dr....

Leadership Team

NamePositionTenureCompensationOwnership
Joseph Sinkule
Founderno dataUS$853.00kno data
Jeffrey LeBlanc
Chief Financial Officerless than a yearUS$312.88kno data
Peter Moriarty
COO & Chief Business Officerless than a yearUS$283.50k0.94%
$ 72.0k
Miguel Rodriguez
Chief Scientific Officer & Consultant1.1yrsno datano data
Shalom Hirschman
Medical Advisor & Independent Directorno dataUS$45.00k1.88%
$ 144.0k
Bradford Navia
Chief Medical Advisorno datano datano data

0.5yrs

Average Tenure

69.5yo

Average Age

Experienced Management: KLTO's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Joseph Sinkule
Founder1.1yrsUS$853.00kno data
Shalom Hirschman
Medical Advisor & Independent Directorno dataUS$45.00k1.88%
$ 144.0k
Robert S. Langer
Member of Scientific Advisory Boardless than a yearno datano data
Jon McGarity
Independent Director1.1yrsno data0.14%
$ 10.8k
Samuel Zentman
Independent Director1.1yrsno datano data
Merit Cudkowicz
Member of Scientific Advisory Boardless than a yearno datano data
Bradley Willcox
Member of Scientific Advisory Boardno datano datano data
Riad El-Dada
Independent Directorless than a yearno datano data
Makoto Kuro-O
Member of Scientific Advisory Boardless than a yearno datano data
D. Willcox
Member of Scientific Advisory Boardno datano datano data
Michio Shimabukuro
Member of Scientific Advisory Boardno datano datano data
Richard Allsopp
Member of Scientific Advisory Boardno datano datano data

0.4yrs

Average Tenure

75yo

Average Age

Experienced Board: KLTO's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 01:52
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Klotho Neurosciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.